Add Yahoo as a preferred source to see more of our stories on Google. Thousands of men suffering from prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Add Yahoo as a preferred source to see more of our stories on Google. A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, experts have said. The treatment, a ...

Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts. This innovative treatment, an immunotherapy designed to harness the ...

The U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee (ODAC) delivered mixed recommendations for ...

An FDA advisory panel has endorsed AstraZeneca’s capivasertib for PTEN-deficient metastatic hormone-sensitive prostate cancer, citing meaningful progression-free survival gains despite toxicity ...

Agency staff expressed uncertainty over whether PFS benefit was "clinically meaningful" ...

A new experimental drug is showing potential in treating prostate cancer and possibly other forms of the disease. A new immunotherapy drug used in a prostate cancer clinical trial is showing early ...

Researchers at the University of British Columbia and BC Cancer have developed a new way to target proteins long considered ...

A prostate cancer study that could change how doctors treat some patients found that widely used hormone-blocking drugs did not improve survival chances for older men whose disease hadn't spread. In ...

The Oncologic Drugs Advisory Committee will meet for the first time in 9 months ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants, investigators found no evidence of an increase in patients' ...